Found 33 matching trials
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks PHASE3 The purpose of this study is to complete the total safety database size for...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants PHASE3 The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity Assessment of Rotavin-M1 in Vietnamese Children PHASE2 This is a multiple-site phase 2b, randomized, placebo control study to eval...
Show More Location
Preventive Medicine Center
Learn More & Join Trial
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants N/A This protocol posting deals with objectives and outcome measures of the pri...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Phase III Study of Liquid Formulation of ROTAVIN PHASE3 This study is conducted to demonstrate non-inferiority in the immunogenicit...
Show More Learn More & Join Trial
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam PHASE3 An open label study to evaluate immunogenicity, safety, and reactogenicity ...
Show More Location
Thai Binh Health Center
Learn More & Join Trial
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. PHASE3 To assess the long-term efficacy and safety of the subjects during the thir...
Show More Location
GSK Investigational Site
Learn More & Join Trial
ROTATEQ Reexamination Study (V260-037) N/A This survey is conducted for preparing application materials for re-examina...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. PHASE2 This study will provide data on the immune response and safety of GSK Biolo...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants PHASE4 The purpose of this study is to evaluate the immunogenicity and safety of t...
Show More Location
GSK Investigational Site
Learn More & Join Trial